publication . Article . 2016

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Name: Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium
Keywords: Research Article, Breast cancer, CHEK2, CHK2, I157T, 1100delC, Survival, Pathology, Gene expression, -, Medizinische Fakultät, breast cancer, CHEK2, CHK2, I157T, 1100delC, survival, pathology, gene expression, MAMMARY-GLAND DEVELOPMENT, GENE-EXPRESSION, DNA-DAMAGE, INTRINSIC SUBTYPES, PROGNOSTIC-SIGNIFICANCE, CHEK2 MUTATIONS, RISK, CHEK2-ASTERISK-1100DELC, SUSCEPTIBILITY, WOMEN, 3122 Cancers, Journal Article, Medicine(all)

Taru A. Muranen; Carl Blomqvist; Thilo Dörk; Anna Jakubowska; Päivi Heikkilä; Rainer Fagerholm; Dario Greco; Kristiina Aittomäki; Stig E. Bojesen; Mitul Shah; ...

View all 44 authors

Open Access

Published: 03 Oct 2016 Journal: Breast Cancer Research (issn: 1465-542X,

Summary
Supplementary outcomes

Abstract

UK funding includes Cancer Research UK and the UK National Institute for Health Research Biomedical Research Centre. For more information on funding, please look at the article.

Persistent Identifiers

doi: 10.17863/cam.6348 , 10.17863/cam.6824 , 10.1186/s13058-016-0758-5

pmc: PMC5048645

pmid: 27716369

handle: 20.500.11820/54059958-3564-48ee-bfce-d516910c6bb5

Subjects

Medical Subject Headings: skin and connective tissue diseases

Fields of Science and Technology classification: 03 medical and health sciences0302 clinical medicine0301 basic medicine030220 oncology & carcinogenesis030104 developmental biology

Sustainable Development Goals: 10. No inequality

free text keywords: Research Article, Breast cancer, CHEK2, CHK2, I157T, 1100delC, Survival, Pathology, Gene expression, -, Medizinische Fakultät, breast cancer, CHEK2, CHK2, I157T, 1100delC, survival, pathology, gene expression, MAMMARY-GLAND DEVELOPMENT, GENE-EXPRESSION, DNA-DAMAGE, INTRINSIC SUBTYPES, PROGNOSTIC-SIGNIFICANCE, CHEK2 MUTATIONS, RISK, CHEK2-ASTERISK-1100DELC, SUSCEPTIBILITY, WOMEN, 3122 Cancers, Journal Article, Medicine(all), ddc:610, Gene expression profiling, Medicine, business.industry, business, Proportional hazards model, Breast cancer, medicine.disease, CDH1, biology.protein, biology, CHEK2, Oncology, medicine.medical_specialty, Surgical oncology, Internal medicine, Cancer, PAM50 Gene Expression Signature

Related Organizations

University of California, Los Angeles
United States
University of Oulu
Finland
Mayo Clinic

Funded by

AKA| Search for novel genes in heritable predisposition to breast cancer, EC| COGS, NIH| Breast Cancer Family Registry Cohort, NIH| Risk and penetrance of mutations from breast cancer testing panels., AKA| Finnish Centre of Excellence in Cell-Extracellular Matrix Research

Download fromView all 13 versions

ZENODO

Article . 2016

Provider: ZENODO

Edinburgh Research Explorer

Article . 2016

Provider: Edinburgh Research Explorer

Breast Cancer Research

Article

Provider: UnpayWall

Apollo

Article . 2016

Provider: Apollo

Supplementary Outcomes

Any information missing or wrong?Report an Issue

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Supplementary Outcomes

Additional file 2: Figure S1. of Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Additional file 1: Table S1. of Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Additional file 1: Table S1. of Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium

Additional file 2: Figure S1. of Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium